Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 706 AL 720

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

Postuma RB, Gagnon JF, Rompré S, Montplaisir JY.

Neurology. 2010 Jan 19;74(3):239-44. doi: 10.1212/WNL.0b013e3181ca0166.

Association of anosmia with autonomic failure in Parkinson disease

Goldstein DS, Sewell L, Holmes C.

Neurology. 2010 Jan 19;74(3):245-51. doi: 10.1212/WNL.0b013e3181ca014c.

Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?

Lee DW, Andersen JK.

J Neurochem. 2010 Jan;112(2):332-9. doi: 10.1111/j.1471-4159.2009.06470.x.

Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease

Antonini A, Chaudhuri KR, Martinez-Martin P, Odin P.

CNS Drugs. 2010 Feb;24(2):119-29. doi: 10.2165/11310940-000000000-00000.

Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery

Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A.

Curr Med Chem. 2010;17(8):759-66. doi: 10.2174/092986710790514480.

Targeted hydrolysis of Beta-amyloid with engineered antibody fragment

Kasturirangan S, Sierks M.

Curr Alzheimer Res. 2010 May;7(3):214-22. doi: 10.2174/156720510791050876.

Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries

Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA.

Neuroepidemiology. 2010;34(3):143-51. doi: 10.1159/000275491. Epub 2010 Jan 15.

Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation

Henkin RI, Potolicchio SJ, Levy LM, Moharram R, Velicu I, Martin BM.

Am J Med Sci. 2010 Mar;339(3):249-57. doi: 10.1097/MAJ.0b013e3181cda0e3.

The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation

Kumar A, Greggio E, Beilina A, Kaganovich A, Chan D, Taymans JM, Wolozin B, Cookson MR.

PLoS One. 2010 Jan 15;5(1):e8730. doi: 10.1371/journal.pone.0008730.

Treadmill training for patients with Parkinson's disease

Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007830. doi: 10.1002/14651858.CD007830.pub2.

Paraquat and Parkinson's disease

Berry C, La Vecchia C, Nicotera P.

Cell Death Differ. 2010 Jul;17(7):1115-25. doi: 10.1038/cdd.2009.217. Epub 2010 Jan 22.

Levodopa delivery systems: advancements in delivery of the gold standard

Ngwuluka N, Pillay V, Du Toit LC, Ndesendo V, Choonara Y, Modi G, Naidoo D.

Expert Opin Drug Deliv. 2010 Feb;7(2):203-24. doi: 10.1517/17425240903483166.

Lessons from the rotenone model of Parkinson's disease

Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG.

Trends Pharmacol Sci. 2010 Apr;31(4):141-2; author reply 142-3. doi: 10.1016/j.tips.2009.12.006. Epub 2010 Jan 22.

Would the elderly be better off if they were given more placebos?

Cherniack EP.

Geriatr Gerontol Int. 2010 Apr;10(2):131-7. doi: 10.1111/j.1447-0594.2009.00580.x. Epub 2010 Jan 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias